Michael Klein

Partner
Full contact info

Experience

WeWork Announces Emergence From Chapter 11

June 13, 2024

Cooley advised Yardi Systems, a large software corporation with offices worldwide, in connection with WeWork’s emergence from Chapter 11 and completion of WeWork’s global operational and financial restructuring.

Read more

Related contacts

C. Thomas Hopkins
Partner, Los Angeles Santa Monica
Logan Tiari
Partner, Los Angeles Downtown
Michael Klein
Partner, New York
Lauren A. Reichardt
Partner, New York
Mischi a Marca
Partner, San Francisco
Ellie Seber
Partner, Los Angeles Santa Monica
Ian Shapiro
Partner in Charge – New York, New York
Howard Morse
Partner, Washington, DC
Megan Browdie
Partner, Washington, DC
Philip Bowman
Partner, New York
David Dalton
Associate, Los Angeles Santa Monica
Steven M. Dunst
Partner, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Patrick Gibbs
Partner, Palo Alto
Austin Holt
Partner, Los Angeles Santa Monica
Erin J. Kirchner
Partner, Chicago
Xander Lee
Partner, Los Angeles Santa Monica
Cullen Drescher Speckhart
Partner in Charge – Washington, DC, Washington, DC
Jeffrey J. Tolin
Partner, New York
Aric Wu
Partner, New York
Su Lian Lu
Special Counsel, Los Angeles Santa Monica
Stella Sarma
Special Counsel, Brussels
Joshua Siegel
Special Counsel, Washington, DC
Reed Smith
Special Counsel, New York
James C. Allen
Associate, Los Angeles Santa Monica
Michael Aridi Barake
Associate, Los Angeles Santa Monica
Julia R. Brinton
Associate, Washington, DC
Grady Chang
Associate, Los Angeles Santa Monica
Sarah Choi
Associate, Los Angeles Santa Monica
Cristina Ferruolo
Associate, San Diego

Related Practices & Industries

Brii Biosciences Announces Agreements to Acquire VBI Vaccines’ IP Rights in BRII-179

February 14, 2024

Cooley advised Brii Biosciences on its agreements with VBI Vaccines (NASDAQ: VBIV) to ensure expansion and control of future clinical and commercial supplies of BRII-179, a late-stage clinical asset in Brii Bio’s hepatitis B virus functional cure portfolio. With operations in major biotechnology centers in the US and China, Brii Bio (HKSE: 2137) is a Hong Kong Stock Exchange-listed biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Rama Padmanabhan
Partner, San Diego
Rajdeep Roger Bains
Associate, San Diego
Jason Savich
Partner, San Francisco
Lila Hope
Partner, Palo Alto
Michael Klein
Partner, New York
Michelle Garcia Schulman
Partner, Reston
Matthew S. Scarano
Associate, San Diego
Jameson Davis
Associate, Boston
Kaiting Yang
Associate, Hong Kong
Ross Eberly
Partner, Los Angeles Santa Monica
Jeffrey J. Tolin
Partner, New York
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Robert Eisenbach
Of Counsel, San Francisco
Rena Kaminsky
Special Counsel, Palo Alto
Olya Antle
Associate, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Yoni Horn
Associate, Los Angeles Santa Monica
Patrick Sharma
Associate, Los Angeles Santa Monica
Lunga Su
Associate, Shanghai
Yiying Wang
Associate, Shanghai

Related Practices & Industries

Blue Owl Capital Invests up to $1.05 Billion in BridgeBio Pharma

January 17, 2024

Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Michael Tollini
Partner, Washington, DC
Addison Pierce
Associate, Chicago
Matt Kong
Associate, San Francisco
Ivor Elrifi
Partner, New York
Xander Lee
Partner, Los Angeles Santa Monica
Geoffrey Spolyar
Partner, Boston
Jon Cousin
Partner, Washington, DC
Steve Flores
Partner, Chicago
Phil Mitchell
Partner, New York
Michael Egan
Partner, Washington, DC
Jeffrey J. Tolin
Partner, New York
Michael Klein
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Susan Piascik Christoff
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Cathy Hershcopf
Senior Counsel, New York
Stevie Yu
Associate, New York
Yichao Zhang
Associate, New York
Rodrigo Huerta
Associate, Chicago
Jackson Alldredge
Associate, Colorado
Amanda Pacheco
Associate, Palo Alto
Celine Koh
Associate, Palo Alto
Jameson Davis
Associate, Boston
Allison Kutner
Associate, New York
Matthew S. Scarano
Associate, San Diego
Xueqing Li
Associate, San Francisco
Mor Agam
Associate, New York
Miriam Peguero Medrano
Associate, Chicago
Sam Rabuck
Associate, Chicago
Chris Rhem
Paralegal Specialist, San Francisco
Veronica Cortes
Paralegal Specialist, New York
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Jason Minio
Paralegal Specialist, Boston
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Blue Owl Capital Invests up to $140 Million in XOMA Corporation

December 19, 2023

Cooley advised Blue Owl Capital, a top asset manager that is redefining alternatives, on its strategic investment – consisting of a nondilutive, nonrecourse royalty-backed loan of up to $140 million – in XOMA Corporation, a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Mischi a Marca
Partner, San Francisco
Addison Pierce
Associate, Chicago
Xander Lee
Partner, Los Angeles Santa Monica
Geoffrey Spolyar
Partner, Boston
Ivor Elrifi
Partner, New York
Michael Klein
Partner, New York
Annie Froehlich
Partner, Washington, DC
Yichao Zhang
Associate, New York
Xueqing Li
Associate, San Francisco
Patrick Sharma
Associate, Los Angeles Santa Monica
Cameron Hajialiakbar
Associate, Los Angeles Santa Monica
Evan Lazerowitz
Associate, New York
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

Thirty Madison Acquires Assets From The Pill Club in Section 363 Sale

June 20, 2023

Cooley advised Thirty Madison, a family of specialized healthcare brands, in its acquisition of certain assets from The Pill Club, following a sale process conducted by The Pill Club under Section 363 of the US Bankruptcy Code.

Read more

Related contacts

Bill Roegge
Partner, New York
Michael Klein
Partner, New York
Adam Dinow
Partner, New York
Eileen Marshall
Partner, Washington, DC
Howard Morse
Partner, Washington, DC
Gerard O'Shea
Partner, New York
Jason Savich
Partner, San Francisco
Judd Lauter
Special Counsel, San Francisco
Nathan Baum
Associate, New York
Daniel Han
Associate, New York
Lauren A. Reichardt
Partner, New York
DeVon Barnett
Associate, Washington, DC
Scott D. Rudin
Associate, New York
Mor Agam
Associate, New York
Sai Yarramalla
Associate, Palo Alto
Lois NaYeon Yoo
Associate, New York
Addison Pierce
Associate, Chicago
Rachel F. Katz
Associate, New York
David Dalton
Associate, Los Angeles Santa Monica
Caitlin Courtney
Partner, Palo Alto
Calvin Lee
Associate, New York
Denise Cahir
Senior Paralegal, New York

Related Practices & Industries

View more

Admissions and credentials

New York

Rankings and accolades

  • New York Super Lawyers: New York Rising Star

  • Legal Aid Society Immigration Law Unit: Outstanding Pro Bono Service

Memberships and affiliations

Turnaround Management Association